Health
FDA Panel Votes to Add Peptides to Compounding List
The FDA's Pharmacy Committee voted in favor of adding peptides to the list of substances compounding pharmacies can produce, despite opposition from agency scientists. The decision is expected to have significant implications for drug development and regulation.
Coverage timeline — 1 article
The Hill
The Food and Drug Administration's (FDA) committee on compounded drugs on Thursday broke with agency scientists and voted in favor of adding peptides to the list of substances compounding pharmacies can make, despite concerns being raised over the lack of demonstrated benefits. The FDA's Pharmacy C
2026-07-23 23:38 UTC